Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

BACKGROUND: The survival benefit of combination antifungal therapy for invasive mucormycosis (IM) in patients with hematologic malignancy (HM) and hematopoietic cell transplant (HCT) is not well defined. METHODS: This multicenter, retrospective study included HM and HCT recipients with proven or pro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Miller, Matthew A, Molina, Kyle C, Gutman, Jonathan A, Scherger, Sias, Lum, Jessica M, Mossad, Sherif B, Burgess, Mary, Cheng, Matthew P, Chuang, Sally T, Jacobs, Samantha E, Melendez, Dante P, Shah, Dimpy P, Zimmer, Andrea, Sohail, M Rizwan, Syed, Sadia, Walker, Randall C, Poeschla, Eric M, Abidi, Maheen Z
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Major Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863870/
https://ncbi.nlm.nih.gov/pubmed/33575424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa646
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares